Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

Allurion Technologies said patients treated with its weight-loss program in a clinical study maintained higher muscle mass and had a bigger decrease in fat percentage. The developer of obesity ...

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ETCompany Participants. Tara Brady - Interim CFO Shantanu Gaur - Founder and CEO. Conference Call ...

Allurion Technologies, Inc., which belongs to the Zacks Medical - Products industry, posted revenues of $5.58 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 2.11%.

Allurion Technologies Inc. (ALUR) reported a notable decline in revenue for Q1 2025, with figures decreasing to $5.6 million from $9.4 million in the same period last year.

Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the recipient of a large decline in short interest during the month of April.As of April 15th, there was short interest totalling ...